Genetic polymorphism of CYP2D6 in patients with systemic lupus erythematosus and systemic sclerosis

Autoimmunity
Malgorzata BaranskaElżbieta Waszczykowska

Abstract

Human organism is constantly exposed to harmful exogenous factors (xenobiotics) including drugs and carcinogenic compounds that can induce development of a large number of diseases. The processes of biotransformation in the organism are multidirectional and xenobiotics can be transformed into active or inactive metabolites via the oxidative route. The knowledge of oxidation polymorphism in the course of systemic lupus erythematosus and systemic sclerosis may be helpful in choosing more efficient and safer therapy, particularly in the case of a disease involving various organs and treated with drugs belonging to diverse therapeutic groups. The aim of the study was to evaluate the CYP2D6 polymorphism in the SLE (systemic lupus erythematosus) and SSc (systemic sclerosis) patients and to investigate a possible correlation with disease susceptibility. The study was carried out in 296 patients: 65 patients with SLE, 81 patients with SSc, and 150 healthy volunteers. The CYP2D6 genotypes were analyzed by polymerase chain reaction fragment length polymorphism (PCR-RFLP) method. The relative risk of developing SSc, expressed by the odds ratio, was three-fold higher for persons with the CYP2D6*1/CYP2D6*4 genotype (OR = 2.9; statistically ...Continue Reading

References

Mar 29, 1990·The New England Journal of Medicine·R M SilverE M Sternberg
Apr 17, 1999·European Journal of Clinical Pharmacology·S KortunayS O Kayaalp
Jun 12, 1999·Annals of the Rheumatic Diseases·S KortunayS O Kayaalp
Dec 22, 1999·Advances in Experimental Medicine and Biology·S von SchmiedebergE Gleichmann
Nov 7, 2002·Carcinogenesis·Christoph SachseUNKNOWN Colorectal Cancer Study Group
Jan 23, 2003·European Journal of Clinical Pharmacology·P NiewinskiZ Forkasiewicz
Oct 11, 2003·Autoimmunity Reviews·Gabriele Valentini
Apr 6, 2004·Trends in Pharmacological Sciences·Magnus Ingelman-Sundberg
May 12, 2004·Free Radical Biology & Medicine·Mohammed TiklyKen I Welsh
Nov 27, 2004·European Journal of Clinical Pharmacology·K SkretkowiczA Sysa-Jedrzejowska
May 21, 2005·Clinical Chemistry·Johanna SistonenAntti Sajantila
Oct 27, 2005·European Journal of Clinical Pharmacology·Marisol LópezMaría Elisa Alonso
Mar 23, 2006·Annual Review of Immunology·Ming O LiRichard A Flavell
Sep 21, 2007·The New England Journal of Medicine·Carmen FonsecaDavid J Abraham
May 16, 2009·European Journal of Clinical Pharmacology·Jadwiga SkretkowiczMariola Rychlik-Sych
Jun 30, 2009·Rheumatology·Takahiko HoriuchiUNKNOWN Kyushu Sapporo SLE Study Group
Feb 1, 2012·Archives of Medical Science : AMS·Jadwiga SkrętkowiczMariola Rychlik-Sych
Jun 5, 2012·Pharmacological Reports : PR·Małgorzata BarańskaJadwiga Skrętkowicz

❮ Previous
Next ❯

Citations

Jul 28, 2013·International Immunopharmacology·Brice KorkmazFrancis Gauthier
May 31, 2017·Clinical Reviews in Allergy & Immunology·Carlo Selmi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Medical Science : AMS
Jadwiga SkretkowiczMariola Rychlik-Sych
International Journal of Dermatology
Mariola Rychlik-SychElżbieta Waszczykowska
© 2022 Meta ULC. All rights reserved